Filing Details
- Accession Number:
- 0001181431-12-066763
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-21 16:44:52
- Reporting Period:
- 2012-12-19
- Filing Date:
- 2012-12-21
- Accepted Time:
- 2012-12-21 16:44:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1123494 | Harvard Bioscience Inc | HBIO | Laboratory Analytical Instruments (3826) | 043306140 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1008643 | David Green | 84 October Hill Road Holliston MA 01746 | President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-12-19 | 48,146 | $3.16 | 1,665,079 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-12-19 | 48,146 | $4.04 | 1,616,933 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-12-20 | 73,591 | $3.16 | 1,690,524 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-12-20 | 73,591 | $4.05 | 1,616,933 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-12-21 | 14,409 | $3.16 | 1,631,342 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-12-21 | 14,409 | $4.06 | 1,616,933 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Stock Option (right to buy) | Disposition | 2012-12-19 | 48,146 | $3.16 | 48,146 | $3.16 |
| Common Stock, Par Value $0.01 Per Share | Stock Option (right to buy) | Disposition | 2012-12-20 | 73,591 | $3.16 | 73,591 | $3.16 |
| Common Stock, Par Value $0.01 Per Share | Stock Option (right to buy) | Disposition | 2012-12-21 | 14,409 | $3.16 | 14,409 | $3.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 88,000 | 2004-01-01 | 2013-04-08 | No | 4 | M | Direct |
| 14,409 | 2004-01-01 | 2013-04-08 | No | 4 | M | Direct |
| 0 | 2004-01-01 | 2013-04-08 | No | 4 | M | Direct |
Footnotes
- Reflects the weighted average price of the shares sold in the reported transaction. These shares were sold in multiple transactions at prices ranging from $4.0100 to $4.1400, inclusive. The reporting person undertakes to provide to Harvard Bioscience, Inc., any security holder of Harvard Bioscience, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Reflects the weighted average price of the shares sold in the reported transaction. These shares were sold in multiple transactions at prices ranging from $4.0000 to $4.1400, inclusive. The reporting person undertakes to provide to Harvard Bioscience, Inc., any security holder of Harvard Bioscience, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Reflects the weighted average price of the shares sold in the reported transaction. These shares were sold in multiple transactions at prices ranging from $3.9300 to $4.0800, inclusive. The reporting person undertakes to provide to Harvard Bioscience, Inc., any security holder of Harvard Bioscience, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Includes (a) a deferred stock award of 66,800 restricted stock units which vest in equal installments on Jan 1, 2013 and Jan 1, 2014; (b) a deferred stock award of 40,312 restricted stock units which vest in equal installments on Jan 1, 2013, Jan 1, 2014 and Jan 1, 2015; (c) a deferred stock award of 88,737 restricted stock units which vest in equal installments on Jan 1, 2013, Jan 1, 2014, Jan 1, 2015 and Jan 1, 2016; and (d) 1,421,084 shares of common stock held by Mr. Green.
- Represents exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan.
Billionaire Hedge Funds
